secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2026-10-16T20:30:28+00:00
Accession:  0001493152-26-047404
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Lucid Diagnostics gets Nasdaq notice: LUCD bid under $1 for 30 days, 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq notified Lucid on Oct 12, 2026 that LUCD's closing bid price was below $1/share for 30 consecutive business days through Oct 9, 2026, per Listing Rule 5550(a)(2).
- Company has until April 12, 2027 (180 calendar days) to regain compliance, requiring a closing bid of at least $1 for a minimum of ten consecutive business days.
- If not cured, Lucid may qualify for an additional 180-day period; otherwise Nasdaq will notify the company of delisting after the initial period ends.
- LUCD continues to trade uninterrupted on the Nasdaq Capital Market; company says it will consider all available options to regain compliance.
- Filing signed Oct 16, 2026 by CFO Dennis McGrath; no other exhibits beyond the XBRL cover page.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226047404/0001493152-26-047404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226047404/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-047404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer